KYMR Kymera Therapeutics, Inc. - Common Stock
$119,95
Prix · Aoû 18, 2026
Données fondamentales au Aoû 5, 2026
Fourchette 52 semaines
$40–$130
89% of range
Note des analystes
BUY
30 analysts
Objectif de cours
$131
+9% upside
P/E (TTM)
-32.5
ROE
-24.4%
Marge nette
-794.0%
À propos de Kymera Therapeutics, Inc. - Common Stock Présentation de l'entreprise depuis Wikipedia
KYMR Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$119.95
Capitalisation Boursière
$9.75B
P/E (TTM)
-32.5
BPA (TTM)
$-3.69
Revenus (TTM)
$39M
Rendement div.
—
ROE
-24.4%
Dette/Capitaux propres
—
Fourchette 52 semaines
$40 – $130
KYMR Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$39M
2019-12-31
→
2025-12-31
BPA
$-3.69
2020-12-31
→
2025-12-31
Flux de trésorerie libre
$-234M
2020-12-31
→
2025-12-31
Marges
-794.0%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
KYMR
Médiane des pairs
P/E (TTM)
-32.5
16.0
P/S (TTM)
248.8
32.5
P/B
6.2
3.9
Price / FCF (Cours / FCF)
-41.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
KYMR
Médiane des pairs
Operating Margin (Marge d'exploitation)
-891.1%
—
Net Profit Margin (Marge nette)
-794.0%
-93.3%
ROA
-22.9%
-22.2%
ROE
-24.4%
-37.6%
ROIC
-22.1%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
KYMR
Médiane des pairs
Current Ratio (Ratio de liquidité)
10.5
5.7
Quick Ratio (Ratio de liquidité réduite)
4.3
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
KYMR
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-16.7%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
-5.7%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
2.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
KYMR
Médiane des pairs
KYMR Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
30 analystes
- Achat fort 10 33,3%
- Achat 16 53,3%
- Conserver 4 13,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
22 analystes · 2026-08-16
Médiane
$133.00
Maintenant
$119.95
Bas
$111.00
Haut
$155.00
Objectif médian
$133.00
+10,9%
Objectif moyen
$130.91
+9,1%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.00%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.62 | $-0.73 | 0.11% |
| 31 mars 2026 | $-0.71 | $-0.90 | 0.19% |
| 31 décembre 2025 | $-0.97 | $-0.81 | -0.16% |
| 30 septembre 2025 | $-0.94 | $-0.82 | -0.12% |
| 30 juin 2025 | $-0.95 | $-0.83 | -0.12% |
| 31 mars 2025 | $-0.82 | $-0.93 | 0.11% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Bilan 21
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $71M | · | $40M | $63M | $62M | · | $44M | $57M | $41M | · | $40M | $47M | $40M | · | $51M | |
| Net Income TTM | $-289M | $-294M | · | $-287M | $-247M | $-219M | · | $-206M | $-182M | $-181M | · | $-176M | $-163M | $-161M | · | $-149M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.6 | -24.4 | · | -16.0 | -13.8 | -9.4 | · | -15.8 | -10.5 | -13.6 | · | -4.5 | -7.8 | -9.9 | · | -7.7 | |
| P/S | 83.6 | 96.8 | · | 101.3 | 48.9 | 28.8 | · | 69.0 | 32.1 | 60.2 | · | 19.1 | 27.1 | 40.8 | · | 23.4 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| P / FCF | · | -76.7 | · | · | · | -22.4 | · | · | · | -52.5 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -2.8% | -4.1% | · | -6.2% | -7.3% | -10.6% | · | -6.3% | -9.5% | -7.4% | · | -22.0% | -12.8% | -10.1% | · | -13.1% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $39M | $47M | $79M | $47M | $73M |
| Marge d'exploitation % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Résultat net | $-311M | $-224M | $-147M | $-155M | $-100M |
| BPA dilué | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Ratio de liquidité réduite | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-234M | $-207M | $-137M | $-156M | $-131M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 305 déclarants · $8.0B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 58 (+19 vs T. préc.) | 22 (-14 vs T. préc.) | 94 (+1 vs T. préc.) | 78 (+5 vs T. préc.) | +11.8M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $992 725 940 | 8 657 242 | 12,48% | Actions |
| FMR LLC | $985 896 654 | 8 597 686 | 12,40% | Actions |
| Avoro Capital Advisors LLC | $857 129 238 | 7 474 747 | 10,78% | Actions |
| BVF INC/IL | $444 008 203 | 3 872 052 | 5,58% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $376 085 378 | 3 279 719 | 4,73% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343 114 771 | 2 992 193 | 4,31% | Actions |
| Siren, L.L.C. | $336 651 626 | 2 935 830 | 4,23% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $336 255 785 | 2 932 378 | 4,23% | Actions |
| Atlas Venture Life Science Advisors, LLC | $326 527 526 | 2 847 541 | 4,11% | Actions |
| STATE STREET CORP | $313 877 705 | 2 737 226 | 3,95% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $181 558 708 | 1 582 987 | 2,28% | Actions |
| Capital Research Global Investors | $159 262 984 | 1 388 881 | 2,00% | Actions |
| Driehaus Capital Management LLC | $105 408 448 | 919 233 | 1,33% | Actions |
| GOLDMAN SACHS GROUP INC | $101 597 391 | 885 998 | 1,28% | Actions |
| Merck & Co., Inc. | $88 544 161 | 772 165 | 1,11% | Actions |
| NORGES BANK | $86 833 399 | 757 246 | 1,09% | Actions |
| FEDERATED HERMES, INC. | $85 933 469 | 749 398 | 1,08% | Actions |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84 955 104 | 740 866 | 1,07% | Actions |
| ALLIANCEBERNSTEIN L.P. | $81 750 884 | 981 521 | 1,03% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $77 152 155 | 672 819 | 0,97% | Actions |
| Holocene Advisors, LP | $72 996 514 | 636 579 | 0,92% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60 744 024 | 529 729 | 0,76% | Actions |
| EVENTIDE ASSET MANAGEMENT, LLC | $57 811 287 | 504 210 | 0,73% | Actions |
| JENNISON ASSOCIATES LLC | $57 676 487 | 502 978 | 0,73% | Actions |
| Woodline Partners LP | $57 434 534 | 500 868 | 0,72% | Actions |
| Rock Springs Capital Management LP | $51 963 399 | 453 156 | 0,65% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $51 570 654 | 449 731 | 0,65% | Actions |
| Boxer Capital Management, LLC | $49 204 897 | 429 100 | 0,62% | Actions |
| Pictet Asset Management Holding SA | $44 984 008 | 395 540 | 0,57% | Actions |
| BRAIDWELL LP | $43 363 951 | 378 163 | 0,55% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $43 100 784 | 375 868 | 0,54% | Actions |
| TWO SIGMA INVESTMENTS, LP | $42 585 457 | 371 374 | 0,54% | Actions |
| Clearbridge Investments, LLC | $39 815 871 | 347 221 | 0,50% | Actions |
| Octagon Capital Advisors LP | $35 547 700 | 310 000 | 0,45% | Actions |
| Nextech Invest Ltd. | $31 981 004 | 278 896 | 0,40% | Actions |
| Alyeska Investment Group, L.P. | $31 701 095 | 276 455 | 0,40% | Actions |
| TD Asset Management Inc | $31 293 443 | 272 900 | 0,39% | Actions |
| TWO SIGMA ADVISERS, LP | $29 085 378 | 373 800 | 0,37% | Actions |
| Commodore Capital LP | $28 667 500 | 250 000 | 0,36% | Actions |
| RTW INVESTMENTS, LP | $27 520 800 | 240 000 | 0,35% | Actions |
| GILDER GAGNON HOWE & CO LLC | $26 265 508 | 229 053 | 0,33% | Actions |
| Polar Capital Holdings Plc | $23 363 668 | 203 747 | 0,29% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22 934 000 | 200 000 | 0,29% | Actions |
| Candriam S.C.A. | $22 096 270 | 192 880 | 0,28% | Actions |
| BANK OF AMERICA CORP /DE/ | $21 627 335 | 188 605 | 0,27% | Actions |
| Eagle Health Investments LP | $19 052 191 | 166 148 | 0,24% | Actions |
| Connor, Clark & Lunn Investment Management Ltd. | $17 189 950 | 149 908 | 0,22% | Actions |
| DIADEMA PARTNERS LP | $17 166 099 | 149 700 | 0,22% | Option d'achat |
| Foresite Capital Management VI LLC | $16 779 890 | 146 332 | 0,21% | Actions |
| WCM INVESTMENT MANAGEMENT, LLC | $16 595 869 | 151 810 | 0,21% | Actions |
| JANE STREET GROUP, LLC | $15 732 724 | 137 200 | 0,20% | Option d'achat |
| Deer Management Co. LLC | $14 436 380 | 125 895 | 0,18% | Actions |
| TimesSquare Capital Management, LLC | $14 063 183 | 168 846 | 0,18% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13 794 801 | 120 300 | 0,17% | Option d'achat |
| Caption Management, LLC | $13 760 400 | 120 000 | 0,17% | Option de vente |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13 703 409 | 119 503 | 0,17% | Actions |
| BOONE CAPITAL MANAGEMENT LLC | $12 977 548 | 113 173 | 0,16% | Actions |
| ARMISTICE CAPITAL, LLC | $12 186 210 | 106 272 | 0,15% | Actions |
| First Turn Management, LLC | $11 757 459 | 102 533 | 0,15% | Actions |
| Ensign Peak Advisors, Inc | $11 198 672 | 97 660 | 0,14% | Actions |
| Squarepoint Ops LLC | $11 144 663 | 97 189 | 0,14% | Actions |
| Swiss National Bank | $10 331 767 | 90 100 | 0,13% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10 262 276 | 89 494 | 0,13% | Actions |
| Bank of New York Mellon Corp | $9 823 664 | 85 669 | 0,12% | Actions |
| RHUMBLINE ADVISERS | $9 252 017 | 80 684 | 0,12% | Actions |
| JPMORGAN CHASE & CO | $9 149 756 | 81 205 | 0,12% | Actions |
| Burkehill Global Management, LP | $8 600 250 | 75 000 | 0,11% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $8 524 567 | 74 340 | 0,11% | Actions |
| CITIGROUP INC | $8 504 959 | 74 169 | 0,11% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8 462 646 | 73 800 | 0,11% | Option de vente |
| CITADEL ADVISORS LLC | $8 328 253 | 72 628 | 0,10% | Actions |
| FIFTH THIRD BANCORP | $7 529 104 | 65 659 | 0,09% | Actions |
| BlackRock, Inc. | $7 486 231 | 65 285 | 0,09% | Actions |
| Yiheng Capital Management, L.P. | $7 274 665 | 63 440 | 0,09% | Actions |
| XTX Topco Ltd | $7 052 320 | 61 501 | 0,09% | Actions |
| FIRST TRUST ADVISORS LP | $7 037 068 | 61 368 | 0,09% | Actions |
| Atika Capital Management LLC | $6 957 488 | 60 674 | 0,09% | Actions |
| Nicholas Investment Partners, LP | $6 257 427 | 54 569 | 0,08% | Actions |
| Ikarian Capital, LLC | $5 779 368 | 50 400 | 0,07% | Option de vente |
| Patient Square Capital LP | $5 446 825 | 47 500 | 0,07% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $5 250 281 | 45 786 | 0,07% | Actions |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5 237 094 | 45 671 | 0,07% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 687 728 | 56 282 | 0,06% | Actions |
| UBS Group AG | $4 678 880 | 40 803 | 0,06% | Actions |
| AXA Investment Managers S.A. | $4 558 224 | 80 534 | 0,06% | Actions |
| VOYA INVESTMENT MANAGEMENT LLC | $4 451 260 | 38 818 | 0,06% | Actions |
| MARSHALL WACE, LLP | $4 273 177 | 37 265 | 0,05% | Actions |
| STATE OF WISCONSIN INVESTMENT BOARD | $4 223 640 | 36 833 | 0,05% | Actions |
| MetLife Investment Management, LLC | $4 184 767 | 36 494 | 0,05% | Actions |
| Rafferty Asset Management, LLC | $4 046 360 | 35 287 | 0,05% | Actions |
| Odyssean, LLC | $3 954 395 | 34 485 | 0,05% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3 851 880 | 33 591 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $3 841 445 | 33 500 | 0,05% | Option de vente |
| Aquilo Capital Management, LLC | $3 791 320 | 138 521 | 0,05% | Actions |
| Nan Fung Group Holdings Ltd | $3 540 436 | 30 875 | 0,04% | Actions |
| Moody Aldrich Partners LLC | $3 440 788 | 30 006 | 0,04% | Actions |
| SEVEN GRAND MANAGERS, LLC | $3 440 100 | 30 000 | 0,04% | Actions |
| 683 Capital Management, LLC | $3 440 100 | 30 000 | 0,04% | Option de vente |
| CITADEL ADVISORS LLC | $3 428 633 | 29 900 | 0,04% | Option d'achat |
| NEW YORK STATE COMMON RETIREMENT FUND | $3 300 203 | 28 780 | 0,04% | Actions |
Initiés de la société 24 initiés · 10 dirigeants · 13 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 7 juillet 2026 M | 666 568 | 0 | 21 | $-34 875 625 |
| Bruce N. Jacobs | Chief Financial Officer | 30 juin 2026 M | 244 883 | 0 | 16 | $-13 917 105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 mai 2026 S | 44 018 | 0 | 29 | $-15 599 618 |
| Terence Rooney | Chief Medical Officer | 27 juillet 2026 A | 38 000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 1 juillet 2026 S | 47 179 | 0 | 9 | $-2 223 845 |
| Jared Gollob | Chief Medical Officer | 2 mars 2026 A | 117 134 | 0 | 18 | $-9 134 491 |
| Brian Adams | Chief Legal Officer | 2 mars 2026 A | 56 625 | 0 | 0 | $0 |
| Ellen Chiniara | Chief Legal Officer | 3 mars 2025 A | 80 085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 1 mars 2023 A | 18 986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 août 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Administrateur | 29 juin 2026 S | 462 856 | 0 | 137 | $-195 559 433 |
| Hrustanovic Gorjan | Administrateur | 24 juin 2026 A | — | 0 | 0 | $0 |
| Elena Ridloff | Administrateur | 24 juin 2026 A | 0 | 0 | 4 | $-1 285 644 |
| Pamela Esposito | Administrateur | 24 juin 2026 A | 1 000 | 0 | 12 | $-3 054 174 |
| Jeffrey W. Albers | Administrateur | 24 juin 2026 A | 0 | 0 | 3 | $-744 757 |
| Victor Sandor | Administrateur | 24 juin 2026 A | — | 0 | 0 | $0 |
| John Maraganore | Administrateur | 24 juin 2026 A | — | 0 | 0 | $0 |
| Leigh Morgan | Administrateur | 18 juin 2024 A | — | 0 | 0 | $0 |
| Joanna Horobin | Administrateur | 7 juin 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Administrateur | 15 juin 2022 A | — | 0 | 0 | $0 |
| Steven Edward Hall | Administrateur | 25 août 2020 C | 2 192 249 | 0 | 0 | $0 |
| Andrew Hedin | Administrateur | 20 août 2020 A | — | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Détenteur de 10% | 18 mai 2021 J | 5 763 012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Détenteur de 10% | 25 août 2020 C | 959 211 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 dépôts | 26 juin 2026 | 6,30% | Amendement | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 dépôts | 11 décembre 2025 | 10,90% | Amendement | Structure du capital | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 dépôts | 9 janvier 2024 | — | Dépôt initial | — | SEC |
| Vertex Pharmaceuticals Incorporated ×2 dépôts | 5 juin 2023 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 64 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 4,23% | 84 154 NS | 31 mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,99% | 10 000 NS | 31 mai 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,76% | 34 157 NS | 30 avril 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 7 506 NS | 30 avril 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 59 553 NS | 30 avril 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 3 077 NS | 30 avril 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,60% | 4 477 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,58% | 522 187 SH | 8 août 2026 | Quotidien |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,50% | 3 204 NS | 31 mai 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 24 697 NS | 30 avril 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55 351 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,34% | 469 031 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,33% | 3 017 NS | 31 mai 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,33% | 1 305 NS | 31 mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 979 NS | 30 avril 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 20 749 NS | 30 avril 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360 394 SH | 8 août 2026 | Quotidien |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871 540 SH | 8 août 2026 | Quotidien |
| IWM · iShares Trust | 0,21% | 1 586 740 SH | 8 août 2026 | Quotidien |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1 938 NS | 30 avril 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32 324 SH | 8 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,14% | 24 820 NS | 30 avril 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 21 796 NS | 30 avril 2026 | N-PORT |
| ITWO · ProShares Trust | 0,12% | 2 699 NS | 31 mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 6 792 NS | 30 avril 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 294 706 NS | 31 mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 5 956 SH | 8 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1 509 269 SH | 8 août 2026 | Quotidien |
| ISCG · iShares Trust | 0,09% | 8 334 SH | 8 août 2026 | Quotidien |
| ISCB · iShares Trust | 0,09% | 2 398 SH | 8 août 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 22 424 SH | 8 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,08% | 143 695 NS | 30 avril 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726 357 SH | 8 août 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9 461 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,08% | 134 854 SH | 8 août 2026 | Quotidien |
| ESML · iShares Trust | 0,08% | 21 257 SH | 8 août 2026 | Quotidien |
| IWN · iShares Trust | 0,07% | 101 814 SH | 8 août 2026 | Quotidien |
| UWM · ProShares Trust | 0,07% | 2 111 NS | 31 mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 21 910 NS | 30 avril 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 2 136 NS | 31 mai 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 61 NS | 31 mai 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2 882 SH | 8 août 2026 | Quotidien |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5 327 NS | 31 mai 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,03% | 1 604 NS | 31 mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 2 239 NS | 31 mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 54 NS | 31 mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 93 115 NS | 30 avril 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 19 514 NS | 31 mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 675 NS | 30 avril 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2 916 NS | 30 avril 2026 | N-PORT |